K. Kitzmiller
Papers
1
Total Citations
5
H-Index
1
About
Dr. K. Kitzmiller is a leading radiation oncologist whose research focuses on de-escalation strategies for head and neck cancers, particularly p16-positive oropharynx cancer. Their most notable contribution is the development of the Selective Avoidance of Nodal VolumEs at Minimal Risk (SAVER) approach, a novel technique designed to reduce treatment toxicity by selectively sparing the contralateral N0 neck from elective nodal irradiation. This work, published in a 2024 Phase I/II trial, has already garnered 5 citations, signaling its early impact on clinical practice. Dr. Kitzmiller’s research aims to minimize long-term side effects—such as dysphagia and xerostomia—without compromising oncologic outcomes, a critical balance in modern radiotherapy. Their achievements include pioneering the SAVER protocol, which challenges conventional nodal coverage paradigms and offers a personalized, risk-adapted treatment framework. By demonstrating promising early outcomes, Dr. Kitzmiller is shaping the future of de-intensified therapy for HPV-related oropharynx cancer, improving quality of life for survivors. Their work stands at the intersection of precision oncology and patient-centered care, making them a key figure in advancing evidence-based radiation techniques.
Research Focus
Key Achievements
Top Papers
- 1